Stalin et al. have recently demonstrated that inhibition of Nox1-mediated signaling via genetic deletion and pharmacological approach (GKT771) reduces lymphangiogenesis, suppresses recruitment of proinflammatory macrophages, and retards tumor growth [94], suggesting that ROS contribute to colon lymphangiogenesis in the cancer setting. Here, NOX1 is linked to neoplasm.